(Q55474948)

12 July 2018

title

Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme. (English)

1 reference

12 July 2018

1 reference

J A Kraus

1

1 reference

12 July 2018

N Glesmann

2

1 reference

12 July 2018

M Beck

3

1 reference

12 July 2018

D Krex

4

1 reference

12 July 2018

T Klockgether

5

1 reference

12 July 2018

G Schackert

6

1 reference

12 July 2018

U Schlegel

7

1 reference

12 July 2018

publication date

1 June 2000

1 reference

12 July 2018

Journal of Neuro-Oncology

published in

1 reference

12 July 2018

volume

48

1 reference

12 July 2018

page(s)

89-94

1 reference

12 July 2018

issue

2

1 reference

12 July 2018

https://scigraph.springernature.com/pub.10.1023/a:1006402614838

exact match

0 references

cites work

Functions of the MDM2 oncoprotein

1 reference

12 December 2020

Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme.

1 reference

12 December 2020

Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas.

1 reference

12 December 2020

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

12 December 2020

Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.

1 reference

12 December 2020

Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas.

1 reference

12 December 2020

CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

1 reference

12 December 2020

TP53 alterations and clinical outcome in low grade astrocytomas.

1 reference

12 December 2020

Long-term glioblastoma multiforme survivors: a population-based study.

1 reference

12 December 2020

Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.

1 reference

12 December 2020

Ten-year survival among patients with supratentorial astrocytomas grade III and IV

1 reference

12 December 2020

Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.

1 reference

12 December 2020

Malignant glioma: who benefits from adjuvant chemotherapy?

1 reference

12 December 2020

PTEN gene mutations are seen in high-grade but not in low-grade gliomas.

1 reference

12 December 2020

Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization.

1 reference

12 December 2020

Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.

1 reference

12 December 2020

Molecular pathogenesis of malignant gliomas

1 reference

12 December 2020

Treatment of malignant glioma in adults.

1 reference

12 December 2020

p53, the cellular gatekeeper for growth and division

1 reference

12 December 2020

Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics.

1 reference

12 December 2020

Long-term survival in patients with glioblastoma multiforme

1 reference

12 December 2020

Progression as exemplified by human astrocytic tumors

1 reference

12 December 2020

Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.

1 reference

12 December 2020

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

1 reference

12 December 2020

Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis

1 reference

12 December 2020

Survival after stereotactic biopsy of malignant gliomas.

1 reference

12 December 2020

Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.

1 reference

12 December 2020

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

1 reference

12 December 2020

CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.

1 reference

12 December 2020

Somatic mutations of PTEN in glioblastoma multiforme.

1 reference

12 December 2020

Alterations of the TP53 gene in human gliomas.

1 reference

12 December 2020

Genetic sub-types of human malignant astrocytoma correlate with survival.

1 reference

12 December 2020

PTEN mutations in gliomas and glioneuronal tumors.

1 reference

12 December 2020

Primary and secondary glioblastomas: from concept to clinical diagnosis

1 reference

12 December 2020

Long-term survival after the diagnosis of malignant glioma: a series of 22 patients surviving more than 4 years after diagnosis

1 reference

12 December 2020

Effects of treatment on long-term survivors with malignant astrocytomas.

1 reference

12 December 2020

The p53 gene and protein in human brain tumors

1 reference

12 December 2020

Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma.

1 reference

12 December 2020

Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.

1 reference

12 December 2020

Long-term survival in patients with malignant astrocytoma.

1 reference

12 December 2020

Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006402614838

1 reference

12 July 2018

Dimensions Publication ID

0 references

1 reference

12 July 2018